tiprankstipranks
Cytosorbents Corp (CTSO)
:CTSO
US Market

Cytosorbents (CTSO) Financial Statements

Compare
473 Followers

Cytosorbents Financial Overview

Cytosorbents's market cap is currently $58.12M. The company's EPS TTM is $-0.356; its P/E ratio is ―; Cytosorbents is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 36.35M$ 29.36M$ 40.11M$ 39.45M$ 22.77M
Gross Profit$ 22.39M$ 15.40M$ 29.06M$ 28.40M$ 15.40M
Operating Income$ -31.21M$ -31.52M$ -22.75M$ -10.37M$ -18.97M
EBITDA$ -29.18M$ -30.00M$ -22.01M$ -9.71M$ -18.74M
Net Income$ -28.51M$ -32.81M$ -24.56M$ -7.84M$ -19.27M
Balance Sheet
Cash & Short-Term Investments$ 14.13M$ 22.14M$ 52.14M$ 71.42M$ 12.23M
Total Assets$ 53.26M$ 63.23M$ 89.52M$ 89.95M$ 27.38M
Total Debt$ 18.31M$ 18.25M$ 13.82M$ 1.03M$ 16.12M
Net Debt$ 4.18M$ -3.89M$ -38.32M$ -70.39M$ 3.89M
Total Liabilities$ 29.99M$ 27.86M$ 26.94M$ 10.73M$ 23.96M
Stockholders' Equity$ 23.28M$ 35.38M$ 62.58M$ 79.22M$ 3.42M
Cash Flow
Free Cash Flow$ -22.59M$ -34.69M$ -18.29M$ -7.29M$ -18.28M
Operating Cash Flow$ -21.66M$ -28.23M$ -14.01M$ -5.61M$ -16.76M
Investing Cash Flow$ -936.24K$ -6.46M$ -4.28M$ -1.68M$ -1.52M
Financing Cash Flow$ 14.47M$ 4.96M$ 715.20K$ 66.35M$ 8.18M
Currency in USD

Cytosorbents Earnings and Revenue History

Cytosorbents Debt to Assets

Cytosorbents Cash Flow

Cytosorbents Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis